Healthcare provider profile · identity verified

Michael Levitz, D.O.

Internal Medicine · NEWBURYPORT, MA · NPI 1417498379

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	749	108
Atorvastatin Calcium	Atorvastatin Calcium	598	100
Eliquis	Apixaban	474	52
Amlodipine Besylate	Amlodipine Besylate	382	65
Gabapentin	Gabapentin	375	54
Metoprolol Succinate	Metoprolol Succinate	331	60
Furosemide	Furosemide	316	56
Metformin Hcl	Metformin Hcl	305	38
Mirtazapine	Mirtazapine	299	43
Metoprolol Tartrate	Metoprolol Tartrate	273	40
Quetiapine Fumarate	Quetiapine Fumarate	268	40
Sertraline Hcl	Sertraline Hcl	243	43
Levothyroxine Sodium	Levothyroxine Sodium	231	59
Tamsulosin Hcl	Tamsulosin Hcl	219	33
Pantoprazole Sodium	Pantoprazole Sodium	211	56
Famotidine	Famotidine	198	26
Torsemide	Torsemide	191	24
Divalproex Sodium	Divalproex Sodium	190	32
Xarelto	Rivaroxaban	173	15
Omeprazole	Omeprazole	142	25
Levetiracetam	Levetiracetam	140	19
Buspirone Hcl	Buspirone Hcl	138	12
Potassium Chloride	Potassium Chloride	130	18
Ondansetron Hcl	Ondansetron Hcl	127	27
Losartan Potassium	Losartan Potassium	117	17
Risperidone	Risperidone	116	16
Donepezil Hcl	Donepezil Hcl	115	19
Warfarin Sodium	Warfarin Sodium	104	suppressed
Lisinopril	Lisinopril	91	33
Simvastatin	Simvastatin	87	21
Fluoxetine Hcl	Fluoxetine Hcl	85	14
Spironolactone	Spironolactone	85	20
Olanzapine	Olanzapine	82	24
Januvia	Sitagliptin Phosphate	81	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	80	suppressed
Duloxetine Hcl	Duloxetine Hcl	76	25
Gentamicin Sulfate In Ns	Gentamicin In Nacl, Iso-Osm	73	suppressed
Clopidogrel	Clopidogrel Bisulfate	70	13
Paroxetine Hcl	Paroxetine Hcl	70	suppressed
Jardiance	Empagliflozin	69	16
Carvedilol	Carvedilol	65	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	15
Midodrine Hcl	Midodrine Hcl	65	13
Rosuvastatin Calcium	Rosuvastatin Calcium	64	16
Pravastatin Sodium	Pravastatin Sodium	60	suppressed
Allopurinol	Allopurinol	56	suppressed
Myrbetriq	Mirabegron	56	suppressed
Hydrocortisone	Hydrocortisone	55	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	54	suppressed
Colchicine	Colchicine	53	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	53	14
Valsartan	Valsartan	49	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	48	31
Rivastigmine	Rivastigmine Tartrate	48	suppressed
Aripiprazole	Aripiprazole	47	suppressed
Trulicity	Dulaglutide	44	suppressed
Digoxin	Digoxin	43	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	41	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Ezetimibe	Ezetimibe	40	suppressed
Finasteride	Finasteride	38	18
Constulose	Lactulose	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Celecoxib	Celecoxib	35	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	33	21
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Prednisone	Prednisone	33	12
Cephalexin	Cephalexin	32	24
Diltiazem 24hr Er	Diltiazem Hcl	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Permethrin	Permethrin	31	30
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	29	15
Memantine Hcl	Memantine Hcl	29	11
Sucralfate	Sucralfate	29	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	28	suppressed
Baclofen	Baclofen	28	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	27	suppressed
Nystatin	Nystatin	27	21
Bupropion Xl	Bupropion Hcl	26	suppressed
Xifaxan	Rifaximin	26	suppressed
Atenolol	Atenolol	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Haloperidol	Haloperidol	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Metolazone	Metolazone	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	21	suppressed
Anastrozole	Anastrozole	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Metronidazole	Metronidazole	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	17
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Topiramate	Topiramate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Novolin R Flexpen	Insulin Regular, Human	19	suppressed
Rytary	Carbidopa/Levodopa	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Levofloxacin	Levofloxacin	18	suppressed
Rivastigmine	Rivastigmine	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Azithromycin	Azithromycin	17	11
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Erythromycin	Erythromycin Base	17	14
Glipizide	Glipizide	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Lactulose	Lactulose	17	suppressed
Sodium Bicarbonate	Sodium Bicarbonate	17	suppressed
Teflaro	Ceftaroline Fosamil Acetate	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Atropine Sulfate	Atropine Sulfate	16	14
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Tetrabenazine	Tetrabenazine	14	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	13	13
Clonidine Hcl	Clonidine Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Lidocaine Hcl	Lidocaine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Naproxen	Naproxen	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error